Boryung Pharmaceutical, Foreign Investors Net Sell 344,695 Shares in Last 5 Days... Stock Price 23,150 KRW (-2.11%)

Boryung Pharmaceutical is trading at 23,150 KRW as of 10:30 AM on the 13th, down 2.11% from the previous day. The trading volume is 1,111,914 shares, which is about 6.3% of the previous day's volume. Boryung Pharmaceutical is known as a manufacturer and seller of pharmaceuticals such as Gelfos and Kanarb.

On January 11, researcher Mung Kyung-jun from IBK Investment & Securities stated, "The company is increasing the added value of its business through active new drug development based on the growth of its blockbuster new drug Kanarb family and anticancer drug products. Based on the stable growth of existing metabolic disease and anticancer drug products, the company is expanding its portfolio of high value-added new drugs and improved new drugs pipelines, so a positive stock price trend is expected to continue." He set the target price for Boryung Pharmaceutical at 36,000 KRW.

Over the past five days, individual investors have net purchased 233,844 shares of Boryung Pharmaceutical, while foreigners and institutions have net sold 344,695 shares and net purchased 127,222 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.